Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

IGC Pharma (IGC) Change in Acquisitions & Divestments (2016 - 2021)

Historic Change in Acquisitions & Divestments for Pharma (IGC) over the last 9 years, with Q1 2021 value amounting to -$3.0 million.

  • Pharma's Change in Acquisitions & Divestments changed N/A to -$3.0 million in Q1 2021 from the same period last year, while for Mar 2022 it was -$1.2 million, marking a year-over-year increase of 19.74%. This contributed to the annual value of $47000.0 for FY2021, which is N/A changed from last year.
  • As of Q1 2021, Pharma's Change in Acquisitions & Divestments stood at -$3.0 million.
  • Over the past 5 years, Pharma's Change in Acquisitions & Divestments peaked at $1.8 million during Q4 2020, and registered a low of -$3.0 million during Q1 2021.
  • Moreover, its 4-year median value for Change in Acquisitions & Divestments was $2053.0 (2017), whereas its average is -$185970.8.
  • Per our database at Business Quant, Pharma's Change in Acquisitions & Divestments soared by 10641.5% in 2017 and then crashed by 10602.27% in 2018.
  • Pharma's Change in Acquisitions & Divestments (Quarter) stood at $1764.0 in 2017, then tumbled by 332.77% to -$4106.0 in 2018, then soared by 45156.02% to $1.8 million in 2020, then tumbled by 264.0% to -$3.0 million in 2021.
  • Its Change in Acquisitions & Divestments stands at -$3.0 million for Q1 2021, versus $1.8 million for Q4 2020 and -$4106.0 for Q1 2018.